That's where people mix up FMI. This isn't just a diagnostic testing company. It's a paradigm shift in treating cancer, effectively Big Data, Smart Medicine. 10 years from now we'll look back on how cancer was treated and it will seem crude. Instead, you'll send a piece of tumor off to FMI (or similar company), and they'll send you back the exact recipe to treat it based on data gathered over a decade of trials. You won't need to be at an academic institution, or endure trial after failed trial of drugs that make you sick. You'll get a customized treatment plan suited tuned exactly for you. The cost savings with this approach are significant. Buy and Hold. That's what Roche did.